In the screening setting, a multi-marker panel containing HP, LRG1 and PON3 had an AUC of 0.65 for detection of advanced adenomas and another panel, optimized for detecting colorectal cancer, reached an AUC of 0.79. This evidence concerns the gene PON3 and adenoma.